Wire Stories
-
599BIO-key Expands Product Line and Market Reach with Launch of FIDO2 Compliant Security Keys in a Variety of Form Factors
WALL, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of Identity and Access Management (IAM)...
-
575Fabrinet Receives Cisco 2021 EMS Partner of the Year Award
BANGKOK–(BUSINESS WIRE)–#Fabrinet–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services (EMS) to original...
-
573
Fabrinet Receives Cisco 2021 EMS Partner of the Year Award
BANGKOK–(BUSINESS WIRE)–#Fabrinet–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services (EMS) to original...
-
662
Bio-Thera Solutions and Intract Pharma Enter Global Collaboration and License Agreement for Soteria� and Phloral� Drug Delivery Technologies to Enable Development of Oral Antibody Medicines
GUANGZHOU, China–(BUSINESS WIRE)–#IBD–Bio-Thera Solutions, Ltd. (688177.SH, �Bio-Thera�) and Intract Pharma (�Intract�) announced a global collaboration and licensing agreement that gives Bio-Thera access...
-
583
Bio-Thera Solutions and Intract Pharma Enter Global Collaboration and License Agreement for Soteria� and Phloral� Drug Delivery Technologies to Enable Development of Oral Antibody Medicines
GUANGZHOU, China–(BUSINESS WIRE)–#IBD–Bio-Thera Solutions, Ltd. (688177.SH, �Bio-Thera�) and Intract Pharma (�Intract�) announced a global collaboration and licensing agreement that gives Bio-Thera access...
-
1.3K
AnHeart and Innovent Announce Interim Data from Phase ? Trial (TRUST) of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting
In the crizotinib treatment-na�ve patient group (n=21), the confirmed objective response rate (ORR) was 90.5% (19/21) and the disease control rate (DCR)...
-
1.3K
AnHeart and Innovent Announce Interim Data from Phase ? Trial (TRUST) of Taletrectinib in ROS1-Positive NSCLC at the CSCO 2021 Annual Meeting
In the crizotinib treatment-na�ve patient group (n=21), the confirmed objective response rate (ORR) was 90.5% (19/21) and the disease control rate (DCR)...
-
784
The World Economic Forum Welcomes Western Digital to Prestigious Global Lighthouse Network
Western Digital�s smart facilities in Malaysia and Thailand are the first Lighthouses to be accepted in these countries Award recognizes leadership in...
-
569
D&D Pharmatech Announces Agreement with Salubris Pharmaceuticals for Licensing and Development of DD01 in China
D&D will receive an upfront payment of $4 million and is eligible to receive additional undisclosed milestone payments upon achievement of certain...
-
565
Ingram Micro Commerce & Lifecycle Services Executive Receives Supply Chain Award
AUCKLAND, New Zealand–(BUSINESS WIRE)–#3pl—Ingram Micro Commerce & Lifecycle Services today announced that Lisa Flynn, director, New Zealand, has been recognized in Supply...
